Now showing items 1-6 of 6

  • Clinical trials in restless legs syndrome - Recommendations of the European RLS study group (EURLSSG) 

    Trenkwalder, C.; Kohnen, R.; Allen, R. P.; Benes, H.; Ferini-Strambi, L.; Garcia-Borreguero, D.; Hadjigeorgiou, G. M.; Happe, S.; Hogl, B.; Hornyak, M.; Klein, C.; Nass, A.; Montagna, P.; Oertel, W. H.; O'Keeffe, S.; Paulus, W.; Poewe, W.; Provini, F.; Pramstaller, P. P.; Sieminski, M.; Sonka, K.; Stiasny-Kolster, K.; de Weerd, A.; Wetter, T. C.; Winkelmann, J.; Zucconi, M. (2007)
    The European Restless Leas Syndrome (RLS) Study Group (EURLSSG) is an association of European RLS experts who are actively involved in RLS research. A major aim of the Study Group is the development and continuous improvement ...
  • Low RLS prevalence and awareness in central Greece: an epidemiological survey 

    Hadjigeorgiou, G. M.; Stefanidis, I.; Dardiotis, E.; Aggellakis, K.; Sakkas, G. K.; Xiromerisiou, G.; Konitsiotis, S.; Paterakis, K.; Poultsidi, A.; Tsimourtou, V.; Ralli, S.; Gourgoulianis, K.; Zintzaras, E. (2007)
    Restless legs syndrome (RLS) is a sensorimotor disorder with a general population prevalence of 3-10%. A single, previous epidemiological study performed in southeast Europe reported the lowest prevalence rate amongst ...
  • The MoCA Well-suited screen for cognitive impairment in Parkinson disease 

    Dalrymple-Alford, J. C.; MacAskill, M. R.; Nakas, C. T.; Livingston, L.; Graham, C.; Crucian, G. P.; Melzer, T. R.; Kirwan, J.; Keenan, R.; Wells, S.; Porter, R. J.; Watts, R.; Anderson, T. J. (2010)
    Objective: To establish the diagnostic accuracy of the Montreal Cognitive Assessment (MoCA) when screening externally validated cognition in Parkinson disease (PD), by comparison with a PD-focused test (Scales for Outcomes ...
  • Progressive development of augmentation during long-term treatment with levodopa in restless legs syndrome: results of a prospective multi-center study 

    Hogl, B.; Garcia-Borreguero, D.; Kohnen, R.; Ferini-Strambi, L.; Hadjigeorgiou, G.; Hornyak, M.; de Weerd, A.; Happe, S.; Stiasny-Kolster, K.; Gschliesser, V.; Egatz, R.; Frauscher, B.; Benes, H.; Trenkwalder, C.; Hening, W. A.; Allen, R. P. (2010)
    The European Restless Legs Syndrome (RLS) Study Group performed the first multi-center, long-term study systematically evaluating RLS augmentation under levodopa treatment. This prospective, open-label 6-month study was ...
  • Randomized Trials of Dopamine Agonists in Restless Legs Syndrome: A Systematic Review, Quality Assessment, and Meta-Analysis 

    Zintzaras, E.; Kitsios, G. D.; Papathanasiou, A. A.; Konitsiotis, S.; Miligkos, M.; Rodopoulou, P.; Hadjigeorgiou, G. M. (2010)
    Background: The use of dopamine agonists (DAs) for the treatment of restless legs syndrome (RLS) has been assessed in numerous randomized clinical trials (RCTs). Objectives: The aims of this study were to assess the reporting ...
  • The role of SOAT-1 polymorphisms in cognitive decline and delirium after bypass heart surgery 

    Tagarakis, G. I.; Tsolaki-Tagaraki, F.; Tsolaki, M.; Diegeler, A.; Kazis, D.; Rouska, E.; Papassotiropoulos, A. (2007)
    Background Cognitive decline (CD) and delirium (PD) are commonly observed complications after bypass heart surgery. In this study we aimed to investigate whether certain genetic factors (alleles of the SOAT-1 gene) play a ...